Breaking News: MNMD – Market Insights, Analysis & Latest Updates

MNMD

MindMed CEO Robert Barrow sells shares worth over $118,000

MindMed CEO Robert Barrow sold shares to meet tax obligations while maintaining significant holdings, amid fluctuating analyst ratings and promising developments for treatments in mental health.

investing.com • 26/09/2024 - 00:32 AM

MNMD

Mind Medicine's chief medical officer sells shares worth over $41,000

MindMed's executive sells shares for tax obligations; company sees FDA breakthrough for MM-120, secures patent, plans funding, and mixed analyst outlook on shares.

investing.com • 26/09/2024 - 00:32 AM

MNMD

MindMed executive sells shares worth over $14k

MindMed's CFO sold shares to cover tax obligations. The company has undergone significant developments, including fundraising and patent acquisition, attracting analyst attention and investor scrutiny.

investing.com • 26/09/2024 - 00:31 AM

MNMD

MindMed executive sells over $26k in company stock

Mark Sullivan, MindMed's Chief Legal Officer, sold shares as part of a trading plan; the company secured a new patent and raised funds for its anxiety and depression treatments.

investing.com • 26/09/2024 - 00:29 AM

Greed and Fear Index

Note: The data is for reference only.

Greed

MindMed CEO Robert Barrow sells shares worth over $118,000

Mind Medicine's chief medical officer sells shares worth over $41,000

MindMed executive sells shares worth over $14k

MindMed executive sells over $26k in company stock

Currency